Pharmacovigilance Assessment of PD-1 Antibody Therapy in Head and Neck Cancer: Risk Factor Analysis Using FAERS Database

Clinical Therapeutics 2026

View at publisher
Authors: Qian Gao, Qian Gao, Linli Xie, Linli Xie, Yu Q, Jiangchuan Xie
DOI: 10.1016/j.clinthera.2025.12.001
Cited by: 1
References: 51

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Head and Neck Cancer Studies HER2/EGFR in Cancer Research

Publication details

Journal / source
Clinical Therapeutics
Publisher
Elsevier BV
Volume
48
Issue
3
Pages
258–268
Publication date
7 February 2026
Language
EN